Hepatitis Diagnostic Test Market Analysis by Type (Imaging Test, Blood Test, Liver Biopsy), and by Region - Forecast to 2029

Request Sample Page

The global hepatitis diagnostic test market size is estimated to be USD 7,821.5 million in 2021 and is expected to witness a CAGR of 6.89% during the forecast period. Shift from traditional technologies to molecular diagnostic technologies is a key driver for the growth of the global hepatitis diagnostic test market. Additionally, an increase in global cases of hepatitis and growing investment in R&D activities for new technologies are some of the other drivers propelling the growth. Nevertheless, the high cost of tests and lack of knowledge regarding diagnostic among developing economies are expected to restrain the growth.

Global Hepatitis Diagnostic Test Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Type

Based on type, the market is categorized into imaging test, blood test, and liver biopsy. The blood test segment accounted for the major revenue in 2021 and is projected to maintain its dominance over the forecast period. The growth is due to the large number of samples that are collected and blood test is the first method for detecting hepatitis worldwide. The liver biopsy segment is anticipated to grow at a lucrative CAGR during the forecast period, due to the fact that to get knowledge about the type of viral strain that has affected the patient.

Regional Insights

In 2021, North America accounted for the largest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the easy availability of advanced diagnostic tools, growing awareness about various diagnostic instruments, and market growth in Canada owing to the initiatives by the government in this region. Asia Pacific region is projected to exhibit the fastest CAGR over the forecast period owing to the rising demand for detection techniques, new product launches by major pharmaceutical players, and there are increasing cases of hepatitis in this region.

Competitor Insights

Some of the key players in the hepatitis diagnostic test market Siemens AG (Germany); Abbott Laboratories (U.S.); MedMira Inc (Canada); Qaigen Inc (U.S.); Beckman Coulter Inc (Danaher Corporation) (U.S.); F. Hoffmann Roche (Switzerland); Diasorin S.p.A (Italy); bioMeriuex (France); Hologic Inc (U.S.); and Bio-Rad Laboratories, Inc. (U.S.). The leading players operating in the industry are adopting various strategies including R&D investments, adoption of advanced techniques, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The hepatitis diagnostic test market report is categorized into the following segments and subsegments:

Hepatitis Diagnostic Test Market, By Type (Revenue, USD Million, 2021 – 2029)

  • Imaging Test
  • Blood Tests
    • Liver Function Tests
    • Immunoassays
    • Nucleic Acid Tests
  • Liver Biopsy Cytology

Hepatitis Diagnostic Test Market, By Region (Revenue, USD Million, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Hepatitis Diagnostic Test Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Hepatitis Diagnostics Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Hepatitis Diagnostics
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Hepatitis Diagnostics Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Diagnostics tests
    1. Imaging tests
      1. Imaging tests Market Forecast, 2021-2029 (USD Million)
    2. Blood tests
      1. Blood tests Market Forecast, 2021-2029 (USD Million)
    3. Liver biopsy
      1. Liver biopsy Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Hepatitis Diagnostics Market
    1. North America Hepatitis Diagnostics Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
      2. S. Hepatitis Diagnostics Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
        2. Canada Hepatitis Diagnostics Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
  1. Europe Hepatitis Diagnostics Market
    1. Europe Hepatitis Diagnostics Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
      2. Germany Hepatitis Diagnostics Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
        2. UK Hepatitis Diagnostics Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
          2. France Hepatitis Diagnostics Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
            2. Spain Hepatitis Diagnostics Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
              2. Italy Hepatitis Diagnostics Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
                2. Rest of Europe Hepatitis Diagnostics Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
  1. Asia Pacific Hepatitis Diagnostics Market
    1. Asia Pacific Hepatitis Diagnostics Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
      2. Japan Hepatitis Diagnostics Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
        2. China Hepatitis Diagnostics Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
          2. India Hepatitis Diagnostics Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
            2. South Korea Hepatitis Diagnostics Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
              2. Australia Hepatitis Diagnostics Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Hepatitis Diagnostics Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
  1. Latin America Hepatitis Diagnostics Market
    1. Latin America Hepatitis Diagnostics Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
      2. Brazil Hepatitis Diagnostics Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
        2. Mexico Hepatitis Diagnostics Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
          2. Argentina Hepatitis Diagnostics Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
            2. Rest of Latin America Hepatitis Diagnostics Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
  1. MEA Hepatitis Diagnostics Market
    1. MEA Hepatitis Diagnostics Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
      2. GCC Hepatitis Diagnostics Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
        2. South Africa Hepatitis Diagnostics Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
          2. Rest of MEA Hepatitis Diagnostics Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Diagnostics tests, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021-2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Hoffmann-La Roche Ltd. (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Abbott Laboratories (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Siemens Healthineers AG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Bio-Rad Laboratories, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. Danaher Corporation (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. QIAGEN (Netherlands)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. bioMérieux SA (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. DiaSorin S.P.A. (Italy)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Ortho Clinical Diagnostics (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. MedMira Inc. (Canada)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Fujirebio US, Inc. (Japan)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Grifols, S.A. (Spain)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Orasure Technologies (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. GenMark Diagnostics Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Vela Diagnostics (Singapore)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports